InsiderSource
NTRA

Natera, Inc.

SEC CIK 1604821
$226.44 +7.5% · 90 days
90-day buys
$0
0 open-market
90-day sells
$38.41M
83 open-market
Net insider flow
−$38.41M
Net selling
Filings shown
230
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at NTRA have sold a net $38.41M of stock (0 open-market buys vs 83 sells).

Largest recent trade: Botha Roelof sold $6.82M of NTRA, trimming their stake 3%.

Most active filer: Moshkevich Solomon, with 87 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for NTRA, newest first
View on SEC EDGAR ↗
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −0.6%

Botha Roelof sold $1.64M of NTRA, trimming their stake 1%.

−$1.64M
7,032 sh @ $234
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −0.8%

Botha Roelof sold $2.34M of NTRA, trimming their stake 1%.

−$2.34M
9,991 sh @ $235
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −0.8%

Botha Roelof sold $2.27M of NTRA, trimming their stake 1%.

−$2.27M
9,623 sh @ $236
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −0.5%

Botha Roelof sold $1.46M of NTRA, trimming their stake 1%.

−$1.46M
6,173 sh @ $237
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −1.3%

Botha Roelof sold $3.65M of NTRA, trimming their stake 1%.

−$3.65M
15,336 sh @ $238
Advertisement
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025 ΔOwn −1.6%

Botha Roelof sold $4.49M of NTRA, trimming their stake 2%.

−$4.49M
18,839 sh @ $239
NTRA
Natera, Inc.
Sell BOTHA ROELOF · Director · Open-market sale · filed Nov 26, 2025

Botha Roelof sold $119.6K of NTRA.

−$119.6K
500 sh @ $239
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −4.5%

Baynes Roy D. sold $260.6K of NTRA, trimming their stake 5%.

−$260.6K
1,184 sh @ $220
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −3.6%

Baynes Roy D. sold $199.6K of NTRA, trimming their stake 4%.

−$199.6K
900 sh @ $222
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −7.5%

Baynes Roy D. sold $401.2K of NTRA, trimming their stake 8%.

−$401.2K
1,800 sh @ $223
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −8.6%

Baynes Roy D. sold $425.4K of NTRA, trimming their stake 9%.

−$425.4K
1,900 sh @ $224
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −9.3%

Baynes Roy D. sold $423.7K of NTRA, trimming their stake 9%.

−$423.7K
1,884 sh @ $225
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −5.3%

Baynes Roy D. sold $266.8K of NTRA, trimming their stake 5%.

−$266.8K
1,250 sh @ $213
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −7.8%

Baynes Roy D. sold $370.9K of NTRA, trimming their stake 8%.

−$370.9K
1,727 sh @ $215
NTRA
Natera, Inc.
Sell Baynes Roy D. · Director · Open-market sale · filed Nov 21, 2025 ΔOwn −10%

Baynes Roy D. sold $461.3K of NTRA, trimming their stake 10%.

−$461.3K
2,135 sh @ $216
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −1.3%

Moshkevich Solomon sold $287.1K of NTRA, trimming their stake 1%.

−$287.1K
1,450 sh @ $198
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −1.3%

Moshkevich Solomon sold $288.7K of NTRA, trimming their stake 1%.

−$288.7K
1,450 sh @ $199
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Nov 4, 2025 ΔOwn −0.1%

Moshkevich Solomon sold $20K of NTRA.

−$20K
100 sh @ $200
NTRA
Natera, Inc.
Sell Marcus Gail Boxer · Director · Open-market sale · filed Nov 4, 2025 ΔOwn −2.1%

Marcus Gail Boxer sold $24.2K of NTRA, trimming their stake 2%.

−$24.2K
122 sh @ $199
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 29, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $229.4K of NTRA, trimming their stake 1%.

−$229.4K
1,198 sh @ $191
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 29, 2025 ΔOwn −0.9%

Moshkevich Solomon sold $193.9K of NTRA, trimming their stake 1%.

−$193.9K
1,008 sh @ $192
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 22, 2025 ΔOwn −0.2%

Moshkevich Solomon sold $54.9K of NTRA.

−$54.9K
292 sh @ $188
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −0.3%

Moshkevich Solomon sold $64.2K of NTRA.

−$64.2K
404 sh @ $159
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −1.5%

Moshkevich Solomon sold $290.4K of NTRA, trimming their stake 2%.

−$290.4K
1,816 sh @ $160
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Oct 1, 2025 ΔOwn −0.7%

Moshkevich Solomon sold $125.3K of NTRA, trimming their stake 1%.

−$125.3K
780 sh @ $161
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $213.7K of NTRA, trimming their stake 1%.

−$213.7K
1,290 sh @ $166
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −0.4%

Moshkevich Solomon sold $83.2K of NTRA.

−$83.2K
500 sh @ $166
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Sep 5, 2025 ΔOwn −1.0%

Moshkevich Solomon sold $202.9K of NTRA, trimming their stake 1%.

−$202.9K
1,210 sh @ $168
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Aug 15, 2025 ΔOwn −0.7%

Moshkevich Solomon sold $134.8K of NTRA, trimming their stake 1%.

−$134.8K
867 sh @ $155
NTRA
Natera, Inc.
Sell Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS · Open-market sale · filed Aug 15, 2025

Moshkevich Solomon sold $1.2K of NTRA.

−$1.2K
8 sh @ $155
Advertisement

About NTRA insider activity

This page tracks every recent Form 4 filed for Natera, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is NTRA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Natera, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.